Cargando…
The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach
PURPOSE OF REVIEW: Chronic pulmonary aspergillosis (CPA) is a serious long-term fungal disease of the lung with a worldwide prevalence. Treatment of CPA is not straightforward given the often-multiple associated co-morbidities, complex clinical picture, drug interactions, toxicities and intolerances...
Autores principales: | Maghrabi, Firas, Denning, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705730/ https://www.ncbi.nlm.nih.gov/pubmed/29213345 http://dx.doi.org/10.1007/s12281-017-0304-7 |
Ejemplares similares
-
Evaluating the Role of STAT3 in CD4(+) T Cells in Susceptibility to Invasive Aspergillosis
por: Gohir, Wajiha, et al.
Publicado: (2021) -
Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis
por: Román-Montes, Carla M., et al.
Publicado: (2022) -
Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status
por: Heldt, Sven, et al.
Publicado: (2017) -
The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update
por: Jenks, Jeffrey D., et al.
Publicado: (2020) -
Diagnosis of Chronic Pulmonary Aspergillosis: Challenges and Limitations Response to “Diagnosis of Chronic Pulmonary Aspergillosis: Which Is the Best Investigation?” and “Diagnosis of Chronic Pulmonary Aspergillosis”
por: De Oliveira, Vítor Falcão, et al.
Publicado: (2023)